What is clarithromycin used to treat?
Clarithromycin is an antibiotic. It’s used to treat chest infections, such as pneumonia, skin problems such as cellulitis, and ear infections. It’s also used to get rid of Helicobacter pylori, a bacteria that can cause stomach ulcers.
What is clarithromycin used for tonsillitis?
Clarithromycin is used to treat certain bacterial infections, such as pneumonia (a lung infection), bronchitis (infection of the tubes leading to the lungs), and infections of the ears, sinuses, skin, and throat.
Does clarithromycin make you tired?
Clarithromycin oral tablet doesn’t cause drowsiness.
Can clarithromycin cause nightmares?
No class-effect of macrolides has been established though clarithromycin and azithromycin have been reported to induce hallucinations, no reports of nightmares are available. A variety of medications may induce nightmares.
Can clarithromycin treat Covid?
Treatment will last for seven days. Every patient will receive one tablet of 500 mg of clarithromycin every 12 hours….Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early (ACHIEVE)
| Intervention Model Description: | Treatment with clarithromycin |
| Masking: | None (Open Label) |
| Primary Purpose: | Prevention |
Can I take clarithromycin for tonsillitis?
User Reviews for Clarithromycin to treat Tonsillitis/Pharyngitis. Clarithromycin has an average rating of 5.6 out of 10 from a total of 42 ratings for the treatment of Tonsillitis/Pharyngitis. 36% of reviewers reported a positive effect, while 29% reported a negative effect.
Does clarithromycin cause anxiety?
The principal side effects of clarithromycin are gastrointestinal; however, less commonly, CNS side effects have been reported, including dizziness, vertigo, anxiety, insomnia, tinnitus, confusion, disorientation, hallucinations, psychosis, and depersonalisation.
Which is best azithromycin or clarithromycin?
Azithromycin has excellent in vitro activity against H influenzae (MIC90 0.5 microgram/ml), whereas clarithromycin, although less active against H influenzae (MIC90 4.0 micrograms/ml) by standard in vitro testing, is metabolized into an active compound with twice the in vitro activity of the parent drug.